Categories
Pharmaceutical Sciences publication

Ishmael et.all publication announcement

Dr. Jane Ishmael and her lab, in collaboration with Dr. Kerry McPhail and Dr. Ian Ganley (University of Dundee, Scotland) announce the publication of a manuscript entitled “ATG5 Promotes Death Signaling in Response to the Cyclic Depsipeptides Coibamide A and Apratoxin A” in Marine Drugs, 2018 Mar 1;16(3). pii: E77. doi: 10.3390/md16030077

Categories
Front Page grant Mahmud Pharmaceutical Sciences

Mahmud et.al wins NSF grants to advance technologies for nontoxic sunscreen ingredients and improved indoor air quality.

Gadusol Laboratories of Corvallis, Ore., received a $225,000 Phase I SBIR grant to advance a technology for producing UV blocking compounds found in marine life that can be used in environmentally friendly, all-natural sunscreens. –Oregon Best

Categories
Front Page research Sikora

Sikora et al take key step toward gonorrhea vaccine

Research led by co-corresponding authors Aleksandra Sikora of Oregon State University and Nicholas Noinaj of Purdue University provides key structural and functional insights into a multicomponent protein complex known as BAM, short for beta-barrel assembly machinery. Featured in the news.

Categories
grant Pharmaceutical Sciences

Morgun, et al. Awarded Medical Research Foundation Grant

A Medical Research Foundation Grant in the amount of $40,000 in support of your project, “Host-microbiota interactions in a model of immunodeficiency-associated enteropathy,” has been approved for funding. Your award period is March 1, 2018, through February 28, 2019.

Categories
Pharmaceutical Sciences publication

Stevens, Kioussi et al. publication in Scientific Reports

Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice. 

Categories
grant Pharmaceutical Sciences

Mahmud, Philmus, et al. Awarded R01 Grant from NIH/NIADI

A new R01 grant from the NIH/NIAID has been awarded to Dr. Taifo Mahmud and his co-investigator Dr. BJ Philmus entitled “Biosynthetic studies and the development of ribomimetic-based anti-infectives” starting January 8, 2018. Congratulations!